Multiplex Assay Kit for Vitronectin (VTN) ,etc. by FLIA (Flow Luminescence Immunoassay)

V75; VN; VNT; Serum Spreading Factor; Somatomedin B; Complement S-Protein

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Vitronectin (VTN) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Vitronectin (VTN) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Vitronectin (VTN) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Vitronectin (VTN) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 84-102 96
EDTA plasma(n=5) 87-104 98
heparin plasma(n=5) 97-104 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Vitronectin (VTN) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Vitronectin (VTN) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Vitronectin (VTN) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 93-101% 81-92% 88-98% 89-96%
EDTA plasma(n=5) 81-97% 87-95% 96-105% 88-102%
heparin plasma(n=5) 94-102% 80-89% 79-101% 83-93%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:VTN) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Biomedical Engineering and Informatics Application of iTRAQ quantitative proteomics in identification of serum biomarkers in breast cancer IEEE: 6098563
PLoS ONE Identification of Altered Plasma Proteins by Proteomic Study in Valvular Heart Diseases and the Potential Clinical Significance PubMed: PMC3754973
Liver International Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 2-D DIGE Pubmed: 23944848
Analytical Biochemistry A multianalytical approach to investigate the effect of nanofiltration on plasma-derived factor IX clinical lots Pubmed:29154788
Journal of Materials Chemistry B Serum protein adsorption profile on BCP ceramic and influence of the elevated adsorption of adhesive proteins on the behaviour of MSCs Doi: 10.1039/C8TB02283F 
JOURNAL OF NEPHROLOGY Urinary vitronectin identifies patients with high levels of fibrosis in kidney grafts 33275196
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB041Hu02 Recombinant Vitronectin (VTN) Positive Control; Immunogen; SDS-PAGE; WB.
RPB041Hu03 Recombinant Vitronectin (VTN) Positive Control; Immunogen; SDS-PAGE; WB.
RPB041Hu01 Recombinant Vitronectin (VTN) Positive Control; Immunogen; SDS-PAGE; WB.
PAB041Hu02 Polyclonal Antibody to Vitronectin (VTN) WB; IHC; ICC; IP.
PAB041Hu01 Polyclonal Antibody to Vitronectin (VTN) WB; IHC; ICC; IP.
PAB041Hu03 Polyclonal Antibody to Vitronectin (VTN) WB; IHC; ICC; IP.
LAB041Hu71 Biotin-Linked Polyclonal Antibody to Vitronectin (VTN) WB; IHC; ICC.
MAB041Hu22 Monoclonal Antibody to Vitronectin (VTN) WB; IHC; ICC; IP.
SEB041Hu ELISA Kit for Vitronectin (VTN) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB041Hu Multiplex Assay Kit for Vitronectin (VTN) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
PSB041Hu01 Antibody Pair for Vitronectin (VTN) ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSB041Hu01 ELISA Kit DIY Materials for Vitronectin (VTN) Main materials for "Do It(ELISA Kit) Yourself"